Lymphomation News Digest - September 3, 2011

[Guest guest]

Lymphomation News Digest - September 3, 2011

News and Reports: www.lymphomation.org/current.htm

OR www.facebook.com/lymphomation.PAL (requires facebook account)

===Survivorship topics

MSNBC:

Roundup kills weeds, but does it harm us?

Cancerandcareers:

Cancer and work

Cancerandcareers:

Cancer as Inspiration for Career Changes

ACS:

How to find a support group

Cancer and Careers:

Resources for Men working with cancer

MSNBC:

Single and seriously ill - care circles fill in for family

===Outcome Reports / Background

W. Sweetenham:

The Role of Radiolabeled Monoclonal Antibodies as Part of the Conditioning

Regimen for Stem Cell Transplants (autografts)

JNCI:

Should Antioxidants Be Avoided During Chemo and Radiation Therapy?

Pubmed - Leuk Lymphoma:

The Impact of High- Dose Chemotherapy, Autologous Stem Cell Transplantation

and Conventional Chemotherapy on Quality of life of Long Term Survivors with

Follicular Lymphoma.

Systematic Review and Meta-Analysis:

Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell

Lymphoma

Pubmed - Leuk Lymphoma:

Improved outcome for very elderly patients with diffuse large B-cell

lymphoma in the immunochemotherapy era

Pub Med:

Maintenance rituximab following chemo-immunotherapy for mantle cell

lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology

Network.

ls of Hematology:

Replacement of conventional doxorubicin by pegylated liposomal doxorubicin

is a safe and effective alternative in the treatment of NHL patients with

cardiac risk factors

Blood:

Adding Rituxan to chemo alone as first-line therapy improves over-all

survival in elderly patients with Mantle Cell lymphoma

Blood:

Treating limited stage nodular lymphocyte predominant Hodgkin lymphoma

similarly to classical Hodgkin lymphoma with ABVD may improve outcome

Pharmalive:

Study Demonstrates Effectiveness of Extracorporeal Photopheresis in

Early-Stage Cutaneous T-Cell Lymphoma

Jefferson Hospital:

New half-match bone marrow transplant procedure yields promising outcomes

http://bit.ly/pG2zuL

ASH press release:

First injection of cultured red blood cells in human donor

Cancer:

Disease-specific expertise and survival: Lessons from chronic lymphocytic

leukemia (CLL)/small lymphocytic lymphoma (SLL)

===Videos / Webcasts

NCI:

Cancer Research Now: Natural Products Branch (video)

Dr Farnsworth:

The Science of Herbs (video)

PBS NewsHour Video:

Drug Shortages Force Tough Choices for Patients, Doctors

Medscape:

New Way to Predict the Right Drug for the Right Patient (video)

===Advocacy and Notices

PAL:

Lymphoma Awareness Month Brochure PDF

PAL:

Reasons for drug shortages, proposed solutions

and related articles

LLS:

Understanding Your Treatment Options Telephone or web conference 9/14

PAL:

Our Letter to CMS on need to amend reimbursement policy for

radioimmunotherapy

===Clinical Trials

Clinical trial:

Phase 2 Safety and Efficacy Study of CAL-101 (GS-1101) in Relapsed or

Refractory Hodgkin Lymphoma

Cure:

New solutions to boost enrollment are breaking barriers that keep cancer

patients out of clinical trials

Cure:

Abysmal' participation in cancer trials

Press release:

Phase 1b/2 Study of TRU-016 in Combination with Rituxan and Bendamustine in

Relapsed - Indolent Lymphoma

7 Reasons to Consider Clinical Trials:

based on your clinical circumstances

Lymphoma Studies sponsored by CALGB cooperative group - now called the

ALLIANCE

===PAL Updates

Draft:

Is it Ethical to Require a Tissue Biopsy of Participants in Clinical Trials?

Words of encouragement for lymphoma patients

Watchful waiting for indolent lymphomas

Exercise - just " do it "

How indolent Lymphomas are Monitored

Comments on Programming T-cells

to Kill Malignant B-Lymphocytes

To Port or Not to Port - and related

drug administration questions (draft)

PET scan - clinical use

" very little is certain and agreed upon. "

===Food for Thought

NY Times:

Ingredients of Shady Origins, Posing as Supplements

Cancer.gov:

Investigating Nature's Mysteries for Drug development

Terra Sigillata:

The best objective herbal medicine information for less than $100 per year

Oncology Times:

Old vs. New Drug Combinations for Optimal Frontline Therapy for Untreated,

Symptomatic CLL

MD:

The trouble with Dr. Google

Oncology Times:

MUSINGS OF A CANCER DOCTOR:

The Cost of Drugs

NY Times:

Cancer Fighting Words

===Technical/Theory/Preclinical

EmpowHER:

Adcetris Targets CD30 Cells in Hodgkin's Lymphoma

NCCN:

Ability to Create Better, Safer Medicines Brings Hope to Many With Cancer

Medical News Today:

Cancer Viral Therapy Attacks Tumors And Does Not Harm Healthy Tissue

~ Karl

Compiled weekly by Anjou and Karl - mostly Anjou!

PATIENTS (helping-to-make-progress) AGAINST LYMPHOMA

www.lymphomation.org